Literature DB >> 11113230

The value of informant versus individual's complaints of memory impairment in early dementia.

D B Carr1, S Gray, J Baty, J C Morris.   

Abstract

Self-reported versus informant-reported memory problems in nondemented elderly adults and in individuals with very mild and mild dementia of the Alzheimer type (DAT) were correlated with cognitive outcomes. No significant correlations were found between self-reported memory complaints and cognitive performance or (in controls) later development of dementia. In contrast, informant-reported memory loss distinguished nondemented from demented individuals and predicted future diagnosis of DAT.

Entities:  

Mesh:

Year:  2000        PMID: 11113230     DOI: 10.1212/wnl.55.11.1724

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  58 in total

1.  Do general practitioners recognize mild cognitive impairment in their patients?

Authors:  H Kaduszkiewicz; T Zimmermann; H Van den Bussche; C Bachmann; B Wiese; H Bickel; E Mösch; H-P Romberg; F Jessen; G Cvetanovska-Pllashniku; W Maier; S G Riedel-Heller; M Luppa; H Sandholzer; S Weyerer; M Mayer; A Hofmann; A Fuchs; H-H Abholz; M Pentzek
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

2.  Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.

Authors:  John C Morris
Journal:  Arch Neurol       Date:  2012-06

Review 3.  Unawareness of deficits in Alzheimer's disease and other dementias: operational definitions and empirical findings.

Authors:  Eric Ecklund-Johnson; Ivan Torres
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

4.  Ascertaining dementia-related outcomes for deceased or proxy-dependent participants: an overview of the Women's Health Initiative Memory Study supplemental case ascertainment protocol.

Authors:  Sarah A Gaussoin; Mark A Espeland; John Absher; Barbara V Howard; Beverley M Jones; Stephen R Rapp
Journal:  Int J Geriatr Psychiatry       Date:  2011-03-18       Impact factor: 3.485

Review 5.  Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1.

Authors:  Richard Mayeux; Christiane Reitz; Adam M Brickman; Mary N Haan; Jennifer J Manly; M Maria Glymour; Christopher C Weiss; Kristine Yaffe; Laura Middleton; Hugh C Hendrie; Lauren H Warren; Kathleen M Hayden; Kathleen A Welsh-Bohmer; John C S Breitner; John C Morris
Journal:  Alzheimers Dement       Date:  2011-01       Impact factor: 21.566

6.  Comparison of 2 informant questionnaire screening tools for dementia and mild cognitive impairment: AD8 and IQCODE.

Authors:  Mehrdad Razavi; Magdalena I Tolea; Jennifer Margrett; Peter Martin; Andrew Oakland; David W Tscholl; Sarah Ghods; Mazdak Mina; James E Galvin
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Apr-Jun       Impact factor: 2.703

7.  Inclusion of an informant yields strong associations between cognitive complaint and longitudinal cognitive outcomes in non-demented elders.

Authors:  Katherine A Gifford; Dandan Liu; Hugo Carmona; Zengqi Lu; Raymond Romano; Yorghos Tripodis; Brett Martin; Neil Kowall; Angela L Jefferson
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Self-Reported Personality Traits and Informant-Rated Cognition: A 10-Year Prospective Study.

Authors:  Angelina R Sutin; Yannick Stephan; Antonio Terracciano
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

9.  Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN).

Authors:  Martha Storandt; David A Balota; Andrew J Aschenbrenner; John C Morris
Journal:  Neuropsychology       Date:  2013-11-11       Impact factor: 3.295

10.  Subjective memory complaints and concurrent memory performance in older patients of primary care providers.

Authors:  Beth E Snitz; Lisa A Morrow; Eric G Rodriguez; Kimberly A Huber; Judith A Saxton
Journal:  J Int Neuropsychol Soc       Date:  2008-11       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.